Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

CUSIP: 57055L206

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
16,869,505
Total 13F shares
1,936,917
Share change
-7,408
Total reported value
$5,462,150
Price per share
$2.82
Number of holders
27
Value change
-$201,922
Number of buys
8
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 57055L206?
CUSIP 57055L206 identifies MRKR - Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) as of Q3 2024

As of 30 Sep 2024, Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,936,917 shares. The largest 10 holders included NEA Management Company, LLC, Aisling Capital Management LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Invst, LLC, and UBS Group AG. This page lists 27 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.